Related Experiment Videos
Experiences from hypertension trials--effects on stroke and coronary heart disease
1Department of Medicine, University of Lund, Malmö General Hospital, Sweden.
Insights
Blood pressure-lowering drug treatment effectively reduces stroke incidence. However, its impact on preventing coronary heart disease (CHD) requires further investigation, with recent trials suggesting potential benefits of beta-blockers over thiazide diuretics.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Clinical Trials
Background:
- Hypertension management is crucial for preventing cardiovascular events.
- Previous research has established the link between blood pressure control and stroke prevention.
- The efficacy of different antihypertensive drug classes in preventing coronary heart disease (CHD) remains an area of active investigation.
Purpose of the Study:
- To review major hypertension trials and assess the role of blood pressure-lowering drugs in preventing stroke and CHD.
- To clarify the comparative effectiveness of thiazide diuretics and beta-blockers in cardiovascular event prevention.
Main Methods:
- Systematic review and summarization of results from major hypertension clinical trials conducted from the 1970s to the present.
- Analysis of data focusing on stroke incidence, CHD incidence, and mortality rates in treated hypertensive patients.
- Comparison of outcomes associated with thiazide diuretics, beta-blockers, and placebo interventions.
Main Results:
- Established evidence confirms that antihypertensive drug treatment significantly decreases stroke incidence across various hypertension severity levels.
- The effect of blood pressure-lowering drugs on preventing coronary heart disease (CHD) is less clear; early trials showed mixed results for thiazide diuretics.
- Recent studies indicate a potential advantage of cardioselective beta-blockers (e.g., metoprolol) over thiazide diuretics in reducing CHD mortality and overall mortality.
Conclusions:
- Antihypertensive therapy is definitively effective in preventing strokes.
- Further research and analysis are necessary to definitively establish whether beta-blockers offer superior protection against CHD compared to thiazide diuretics.
- The choice of antihypertensive medication may have differential effects on preventing specific cardiovascular outcomes like stroke and CHD.
Abstract:
This review summarises the results of major hypertension trials and addresses the major questions of whether stroke and coronary heart disease (CHD) can be prevented or postponed by blood pressure-lowering drug treatment. Several studies from the 1970s to the 1980s have shown beyond doubt that treatment of high blood pressure decreases the incidence of stroke. Most trials have used thiazide diuretics as active treatment; in one trial the beta-blocker propranolol, compared with placebo, was shown to lower stroke incidence. For thiazide diuretics the preventive effect has been shown for severe, moderate and mild hypertension. The situation regarding CHD is unclear. Early trials with thiazide diuretics showed a lower CHD mortality compared with placebo but no effect on total incidence of CHD events. Three trials during the early 1980s comparing thiazide diuretics and beta-blockers were not able to show a differential effect of the 2 types of drugs. Recently, however, a trial using the cardioselective beta-blocker metoprolol reported a significantly lower CHD mortality and total mortality compared with thiazide diuretics. Further analyses are needed before the question of whether beta-blockers are superior to thiazide diuretics in preventing CHD can be finally answered.